Donation After Circulatory Death in Pediatric Heart Transplantation
Pediatric Transplantation · 2026-05 · 30 (5)
DOI: 10.1111/petr.70329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, online erschienen am 04.05.2026. Verfasst von Sarah Dudley Grorud und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cardiology, University of Virginia Children's Hospital, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Tissue and Organ Procurement, Tissue Donors. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jefferson Trust, AHRQ HHS.
Abstract (Originalsprache)
Purpose
Donation after circulatory death (DCD) is an emerging heart transplantation (HT) strategy with improved waitlist and comparable post‐transplant outcomes to donation after brain death (DBD) in adults. Pediatric DCD‐HT is underutilized but gaining broader adoption. We assessed the impact of DCD listing on waitlist outcomes and graft survival in pediatric HT.
Methods
We queried the OPTN (Organ Procurement and Transplantation Network)/UNOS (United Network for Organ Sharing) database for all pediatric primary isolated HT candidates between January 2021 and June 2024. Waitlist outcomes were compared by final listing type to account for crossovers. Offer dynamics were assessed by average interval between offers stratified by OPTN/UNOS status. Multivariable regression modeled offer frequency as a function of DCD listing. We compared 30‐day survival between recipients of DCD and DBD organs.
Results
Among 2486 candidates, 86 were initially listed eligible for DCD and 2400 for DBD. DCD candidates had higher clinical acuity than DBD candidates. DCD listing was associated with significantly shorter intervals between offers across all statuses and increased offer rate by 134% (95% CI: 92%–186%). Waitlist outcomes did not differ significantly by final listing type. There was no difference in 30‐day survival between DCD and DBD recipients.
Conclusions
DCD listing in pediatric HT is associated with a shorter interval between offers and more frequent offers. Waitlist survival was similar between groups despite DCD candidates being sicker at listing. There was no difference in 30‐day survival between DCD and DBD recipients. These findings suggest that broader adoption of pediatric DCD‐HT can expand access to donor hearts without compromising early post‐transplant outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Cardiology, University of Virginia Children's Hospital, Charlottesville, Virginia, USA.
- Data Science, University of Virginia, Charlottesville, Virginia, USA.
- Systems and Information Engineering, University of Virginia, Charlottesville, Virginia, USA.
- Cardiovascular Surgery, Arkansas Children's Hospital, Little Rock, Arkansas, USA.
ORCID-Profile: Sarah Dudley Grorud, Michael D Porter, Taufiek Konrad Rajab, R Jerome Dixon, Michael McCulloch, Firezer Haregu
Förderung
- Jefferson Trust
- AHRQ HHS
Zitieren
APA
Grorud, S. D., Porter, M. D., Rajab, T. K., Dixon, R. J., McCulloch, M., & Haregu, F. (2026). Donation After Circulatory Death in Pediatric Heart Transplantation. Pediatric Transplantation, 30(5). https://doi.org/10.1111/petr.70329
Vancouver
Grorud SD, Porter MD, Rajab TK, Dixon RJ, McCulloch M, Haregu F. Donation After Circulatory Death in Pediatric Heart Transplantation. Pediatric Transplantation. 2026;30(5). doi:10.1111/petr.70329
BibTeX
@article{Grorud2026,
author = {Grorud, Sarah Dudley and Porter, Michael D and Rajab, Taufiek Konrad and Dixon, R Jerome and McCulloch, Michael and Haregu, Firezer},
title = {Donation After Circulatory Death in Pediatric Heart Transplantation},
journal = {Pediatric Transplantation},
year = {2026},
volume = {30},
number = {5},
doi = {10.1111/petr.70329}
}
EUVIMED